Procedure for Addressing Deviations in Dispensed Quantities
Department | Production/Quality Assurance (QA)/Quality Control (QC)/Warehouse |
---|---|
SOP No. | SOP/Ointment/179 |
Supersedes | V 1.0 |
Page No. | Page X of Y |
Issue Date | [Insert Issue Date] |
Effective Date | [Insert Effective Date] |
Review Date | [Insert Review Date] |
1. Purpose
The purpose of this Standard Operating Procedure (SOP) is to establish a structured approach for identifying, investigating, and addressing deviations in dispensed raw material quantities. Proper handling of deviations ensures batch consistency, prevents formulation errors, and maintains compliance with Good Manufacturing Practices (GMP) and regulatory requirements.
2. Scope
This SOP applies to all personnel responsible for weighing, dispensing, verifying, and approving raw materials in the Production, Quality Assurance (QA), Quality Control (QC), and Warehouse departments.
3. Responsibilities
- Dispensing Operator: Ensures proper weighing and reports any deviations immediately.
- QA Officer: Reviews and approves corrective actions for any deviations.
- QC Analyst: Verifies dispensed quantities and investigates potential issues.
- Warehouse Supervisor: Ensures materials are correctly labeled and stored after weighing.
- Production Supervisor: Oversees the dispensing process and coordinates deviation resolution.
4. Accountability
The QA Manager is accountable for ensuring that all deviation handling activities comply with GMP, FDA, ICH, WHO, and company policies.
5. Procedure
5.1 Identification of Dispensing Deviations
A deviation occurs when the dispensed quantity of raw material does not match the prescribed amount in the Batch Manufacturing Record
- Common causes of deviations include:
- Operator error in weighing.
- Weighing balance calibration issues.
- Material loss during transfer.
- Environmental factors affecting material stability.
- Deviation categories:
- Minor Deviation: Dispensed weight is within a ±1% variance.
- Major Deviation: Dispensed weight exceeds ±1% variance.
- Critical Deviation: Dispensed weight leads to non-compliance or affects product quality.
5.2 Immediate Actions Upon Identifying a Deviation
- Stop the dispensing process immediately.
- Segregate and label the affected material as **”Hold for Investigation.”**
- Notify the QA department and Production Supervisor.
- Record the deviation in the **Dispensing Deviation Log (Annexure-1).**
5.3 Investigation of Deviation
- QA must review the **weighing logs, equipment calibration records, and environmental monitoring data.**
- QC must reweigh the material to verify accuracy.
- If equipment malfunction is suspected:
- The balance must be recalibrated immediately.
- All materials dispensed using the faulty balance must be reviewed.
- If operator error is confirmed:
- The operator must be retrained on proper weighing techniques.
- A Corrective and Preventive Action (CAPA) plan must be implemented.
5.4 Corrective and Preventive Actions (CAPA)
- Corrective Actions:
- Reweigh the material under QA supervision.
- Adjust the batch formulation accordingly.
- Quarantine and dispose of excess or contaminated material.
- Preventive Actions:
- Ensure regular calibration of weighing balances.
- Implement double-checking of weights by a second operator.
- Improve documentation and material handling procedures.
5.5 Post-Deviation Documentation
- Ensure that all deviations and corrective actions are documented in the **Deviation Report (Annexure-2).**
- QA must review and approve all corrective actions before the batch is released for further processing.
- Retain records for **five years** for audit and compliance purposes.
6. Abbreviations
- GMP – Good Manufacturing Practices
- QA – Quality Assurance
- QC – Quality Control
- BMR – Batch Manufacturing Record
- FDA – Food and Drug Administration
- ICH – International Council for Harmonisation
7. Documents
- Dispensing Deviation Log (Annexure-1)
- Deviation Report (Annexure-2)
8. References
- ICH Q7 – GMP for Active Pharmaceutical Ingredients
- WHO Guidelines on Raw Material Handling
- FDA Guidance on Pharmaceutical Manufacturing
9. SOP Version
Version 2.0
10. Approval Section
Prepared By | Checked By | Approved By | |
---|---|---|---|
Signature | |||
Date | |||
Name | |||
Designation | |||
Department |
11. Annexures
Annexure-1: Dispensing Deviation Log
Date | Material Name | Batch No. | Dispensed Quantity | Deviation Type | Operator | QA Review |
---|---|---|---|---|---|---|
02/02/2025 | API X | SOP/Ointment/1001 | 5.2 kg | Overweight | John Doe | Approved |
Annexure-2: Deviation Report
Date | Material Name | Batch No. | Deviation Type | Root Cause | Corrective Action | QA Approval |
---|---|---|---|---|---|---|
02/02/2025 | API X | SOP/Ointment/1001 | Overweight | Operator Error | Reweighed and Adjusted | Approved |
12. Revision History
Revision Date | Revision No. | Details | Reason | Approved By |
---|---|---|---|---|
02/02/2025 | 2.0 | Expanded Deviation Handling Procedures | Improved Compliance | QA Head |